Abortifacient Agents, Nonsteroidal
"Abortifacient Agents, Nonsteroidal" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Non-steroidal chemical compounds with abortifacient activity.
| Descriptor ID |
D000020
|
| MeSH Number(s) |
D27.505.696.875.131.100 D27.505.954.705.131.100
|
| Concept/Terms |
Abortifacient Agents, Nonsteroidal- Abortifacient Agents, Nonsteroidal
- Agents, Nonsteroidal Abortifacient
- Nonsteroidal Abortifacient Agents
- Abortifacient Agents, Non-Steroidal
- Abortifacient Agents, Non Steroidal
- Agents, Non-Steroidal Abortifacient
- Non-Steroidal Abortifacient Agents
|
Below are MeSH descriptors whose meaning is more general than "Abortifacient Agents, Nonsteroidal".
Below are MeSH descriptors whose meaning is more specific than "Abortifacient Agents, Nonsteroidal".
This graph shows the total number of publications written about "Abortifacient Agents, Nonsteroidal" by people in this website by year, and whether "Abortifacient Agents, Nonsteroidal" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2009 | 1 | 1 | 2 |
| 2011 | 1 | 0 | 1 |
| 2013 | 1 | 0 | 1 |
| 2016 | 0 | 1 | 1 |
| 2018 | 0 | 1 | 1 |
| 2020 | 2 | 0 | 2 |
| 2021 | 2 | 0 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Abortifacient Agents, Nonsteroidal" by people in Profiles.
-
Al-Hafez L, Bicocca MJ, Chauhan SP, Berghella V. Prostaglandins for induction in pregnancies with fetal growth restriction. Am J Obstet Gynecol MFM. 2022 03; 4(2):100538.
-
Achenbach AE, Singh S, Jackson B, Caveglia SJ, Berghella V, Seligman NS. Cervical ripening with laminaria tents prior to second trimester induction of labor. J Matern Fetal Neonatal Med. 2022 Dec; 35(25):5807-5812.
-
Berghella V, Bellussi F. Misoprostol before surgical abortion: evidence-based and ready to be incorporated in clinical guidelines to change practice. Am J Obstet Gynecol MFM. 2020 11; 2(4):100254.
-
Perriera L, Creinin MD. Misoprostol before to first-trimester surgical abortion: do not jump on the bandwagon, not all evidence is created equal. Am J Obstet Gynecol MFM. 2020 11; 2(4):100244.
-
Morra I, Ferrara C, Sglavo G, Sansone A, Saccone G, Perriera L, Di Carlo C. Incidence of uterine rupture in second-trimester abortion with gemeprost alone compared to mifepristone and gemeprost. Contraception. 2019 03; 99(3):152-154.
-
Desai A, Fleischer AC, Wahab SA, New M, Smolinsky C, McKenna J, Andreotti R. Sonography of Responsive Versus Nonresponsive Ectopic Pregnancies. J Ultrasound Med. 2016 Jun; 35(6):1341-7.
-
Bracken H, Ngoc NT, Banks E, Blumenthal PD, Derman RJ, Patel A, Gold M, Winikoff B. Buccal misoprostol for treatment of fetal death at 14-28 weeks of pregnancy: a double-blind randomized controlled trial. Contraception. 2014 Mar; 89(3):187-92.
-
Berghella V, Bamfo J. Editors' choice. BJOG. 2011 Dec; 118(13):i-ii.
-
Perriera LK, Reeves MF, Chen BA, Hohmann HL, Hayes J, Creinin MD. Feasibility of telephone follow-up after medical abortion. Contraception. 2010 Feb; 81(2):143-9.
-
Berghella V, Airoldi J, O'Neill AM, Einhorn K, Hoffman M. Misoprostol for second trimester pregnancy termination in women with prior caesarean: a systematic review. BJOG. 2009 Aug; 116(9):1151-7.